Atomoxetine hydrochloride side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Atomoxetine hydrochloride. Common side effects include abdominal pain upper among females and aggression among males.

The phase IV clinical study is created by eHealthMe based on 506 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 28, 2023

506 people who take Atomoxetine Hydrochloride and have side effects are studied.

What is Atomoxetine Hydrochloride?

Atomoxetine hydrochloride has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 522 Atomoxetine hydrochloride users for its effectiveness, alternative drugs and more.

Number of Atomoxetine hydrochloride reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Atomoxetine hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on atomoxetine hydrochloride (the active ingredients of Atomoxetine hydrochloride) and Atomoxetine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Atomoxetine hydrochloride:

Atomoxetine hydrochloride (522 reports)

All Atomoxetine hydrochloride side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Flexeril and Levofloxacin drug interaction - 5 seconds ago
Amphotericin B and Engraft Failure - 6 seconds ago
Trandolapril and Swallowing Difficulty - 20 seconds ago
Treprostinil and Ileitis Aggravated - 33 seconds ago
Rifampin And Isoniazid and Erythema Multiforme - 38 seconds ago
Nicoderm Cq and Tendon Rupture - 46 seconds ago
Isoptin and Biliary Tract Disorder - 47 seconds ago
Hyperthyroidism Aggravated and Abdominal Pain - 48 seconds ago
Protopic and Hepatotoxicity Aggravated - 51 seconds ago
Symbyax and Sumatriptan drug interaction - 54 seconds ago